منابـــع و مراجــــع

[1] Shahnaz Bakand, Amanda Hayes. “Nanoparticles: a review of particle toxicology following inhalation exposure”, Inhal Toxicol, 24(2), 125–135, (2012).

[2] Borm P, Robbins JA, Haubold D, Kuhlbusch S, Fissan T, Donaldson H, Schins KR, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdorster E. “The potential risks of nanomarerials: a review carried out for ECETOC”, Part Fibre Toxicol, 3, p.1–35, (2006).

[3] Song Y, Li X, Du X. “Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma”, Eur Respir J, 34(3), p.559–567, (2009).

[4] Mayo Clinic Staff. "Definition [of pulmonary fibrosis]". Mayo Foundation for Medical Education and Research. Retrieved 26 July (2014), available at: http://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/home/ovc-20211752

[5] سازمان ملّی استاندارد، استاندارد شمارۀ 21206 ، فناوری نانو- راهنمای مشخصه‌یابی فیزیکوشیمیایی مواد نانومقیاس مهندسی‌شده برای ارزیابی توکسیکولوژیک؛ سال انتشار: 1395.

[6] Nancy A. Monteiro-Riviere, C. Lang Tran. “Nanotoxicology: characterization, dosing and health effects”, USA: CRC Press Inc, 14, p.225–236, (2007).

[7] Warheit DB, “Nanoparticles health impacts”, Mater Today, 7(2), p.32–35, (2004).

[8] https://en.wikipedia.org/wiki/Dispersity

[9] Drobne D. “Nanotoxicology for safe and sustainable nanotechnology”, Arh Hig Rada Toksikol, 58(4), p.471–478, (2007).

[10] Oberdörster G, Oberdörster E, Oberdörster J. “Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles”, Environ Health Perspect, 113(7), p.823–839, (2005).

[11] Maynard AD, Baron PA, Foley M, et al, “Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material”, J Toxicol Environ Health, Part A, 67(1), p.87–107, (2004).

[12] Seaton A. “Nanotechnology and the occupational physician”, Occup Med (Lond), 56(5), p.312–316, (2006).

[13] Stine KE, Brown TM. “Principles of Toxicology”, 2th ed, USA (Boca Raton): CRC Press, p.143-163 (1996).

[14] David A, Wagner GR. “Respiratory system. In: Encyclopaedia of occupational health and safety”, 4th ed, Geneva: International Labour Office, 10.1–10.7, (1998).

[15] Schlesinger RB. “Interaction of gaseous and particulate pollutants in the respiratory tract: mechanisms and modulators”, Toxicology, 105(2–3), p.315–325, (1995).

[16] Dechsakulthorn F, Hayes A, Bakand S, Joeng L, Winder C. “In vitro cytotoxicity of selected nanoparticles using human skin fibroblasts”, AATEX, 14, p.397–400, (2008).

[17] Bakand S, Winder C, Khalil C, Hayes A. “Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review”, Inhal Toxicol, 17(13), p.775–787, (2005).

[18] Blank F, Gehr P, Rutishauser RR. “In vitro human lung cell culture models to study the toxic potential of nanoparticles. In:Nanotoxicity: From in vivo and in vitro models to health risks”, UK: John Wily & Sons Ltd, p.379–395, (2009).

[19] Asgharian B, Wood R, Schlesinger RB. “Empirical modeling of particle deposition in the alveolar region of the lungs: a basis for interspecies extrapolation”, Fundam Appl Toxicol, 27(2), p.232–238, (1995).

[20] Rozman KK, Klaassen CD. “Absorption, distribution and excretion of toxicants. In: Casarett and Doull’s Toxicology: the Basic Science of Poisons”, 6th ed, New York: McGraw-Hill, p.105–132, (2001).

[21] Mublfeld C, Gebr P, Rutishauser BR. “Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract”, Swiss Med Wkly 138(27–28), p.387–391, (2008).

[22] Siegmann K, Scherrer L, Siegmann HC. “Physical and chemical properties of airborne nanoscale particles and how to measure the impact on human health”, J Mol Struct (Theochem), 458(1–2), p.191–201, (1999).

[23] Asgharian B, Hofmann W, Miller FJ. “Dosimetry of particles in humans: from children to adults. In: Toxicology of the Lung”, 4th ed, USA (Boca Raton): Taylor & Francis, p.151–195, (2006).

[24] Barile F. “Principles of toxicology testing”, USA (Boca Raton): CRC Press, Taylor & Francis Group, p.147–172, (2008).

[25] Rückerl R, Schneider A, Breitner S, Cyrys J, Peters A. “Health effects of particulate air pollution: A review of epidemiological evidence”, Inhal Toxicol, 23(10), p.555–592, (2011).

[26] Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. “Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition”, Environ Health Perspect, 115(3), p.403–409, (2007).

[27] Donaldson K, Stone V, Gilmour PS, Brown DM, Macnee W. “Ultrafine particles: mechanisms of lung injury”, Phil Trans R Soc Lond A, 358(1775), p.2741–2749. )2000(.